| Summary of Basic and Diluted Earnings Per Share |
Basic and diluted earnings per share were calculated as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Numerator: | | | | | | | | | | | | | | | | | Net income attributable to The Vita Coco Company, Inc. | $ | 35,017 | | | $ | 24,003 | | | $ | 114,942 | | | $ | 65,793 | | | Denominator: | | | | | | | | | Weighted-average number of common shares used in earnings per share—basic | 57,453,252 | | | 56,850,812 | | | 57,274,270 | | | 56,879,627 | | Effect of conversion of stock options and RSUs | 3,378,380 | | | 3,027,790 | | | 3,512,192 | | | 2,952,440 | | | Weighted-average number of common shares used in earnings per share—diluted | 60,831,632 | | | 59,878,602 | | | 60,786,462 | | | 59,832,067 | | | Earnings per share—basic | $ | 0.61 | | | $ | 0.42 | | | $ | 2.01 | | | $ | 1.16 | | | Earnings per share—diluted | $ | 0.58 | | | $ | 0.40 | | | $ | 1.89 | | | $ | 1.10 | |
|
| Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following potentially dilutive securities, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average number of common shares outstanding, as they would be anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Stock options and restricted stock awards | — | | | 201,443 | | | 4,708 | | | 250,878 | |
|